EGFR and cancer: Epidermal growth factor receptor I (EGFR) is overexpressed in all aggressive cancers of epithelial origin, including squamous cell head and neck (90–100%), glioma (90–100%), non-small cell lung (75–90%), colorectal (80–85%), breast (20–30%), and cervical cancers [1,2,3,4,5].